Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. (Q44511458)

3 December 2017

title

Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. (English)

1 reference

3 December 2017

1 reference

Hervé Allain

1

1 reference

3 December 2017

Danièle Bentué-Ferrer

2

1 reference

3 December 2017

Stéphanie Le Breton

3

1 reference

3 December 2017

Elisabeth Polard

4

1 reference

3 December 2017

Jean-Marc Gandon

5

1 reference

3 December 2017

publication date

1 July 2003

1 reference

3 December 2017

published in

Human Psychopharmacology

1 reference

3 December 2017

volume

18

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

369-374

1 reference

Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

3 December 2017

cites work

1 reference

Evaluation of severe insomnia in the general population: results of a European multinational survey

21 January 2018

1 reference

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

21 January 2018

1 reference

Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.

21 January 2018

1 reference

Clinical decision-making in the evaluation and treatment of insomnia

21 January 2018

1 reference

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

21 January 2018

1 reference

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem

21 January 2018

1 reference

Epidemiological evidence for a low abuse potential of zolpidem

21 January 2018

1 reference

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance

21 January 2018

1 reference

Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia

21 January 2018

1 reference

The rating scale preference measure as an evaluative measure in systemic lupus erythematosus.

21 January 2018

1 reference

Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia

21 January 2018

1 reference

Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades

21 January 2018

1 reference

A new design of trial for hypnotics comparison: a double-blind cross-over trial with patient's preference assessment and continuation of the preferred treatment

21 January 2018

1 reference

Zaleplon pharmacokinetics and absolute bioavailability

21 January 2018

1 reference

Review of available instruments and methods for assessing quality of life in anti-anginal trials

21 January 2018

1 reference

7 January 2021

Zaleplon: a review of its use in the treatment of insomnia

1 reference

7 January 2021

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group

1 reference

7 January 2021

[Explanatory or pragmatic trials, the dualism]

1 reference

7 January 2021

The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers

1 reference

7 January 2021

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.500

1 reference

3 December 2017

1 reference